Clinical trial
A Study of Two Parts to Determine the Effect of NWT-03 on Blood Pressure in Healthy Subjects. Part 1: A Dose Ranging, Cross-over Study to Determine the Effect of 1g, 2g & 5gs of NWT-03 Versus Placebo on Blood Pressure in Healthy Subjects.
NCT02148198 is registered in ClinicalTrials.gov with Newtricious R&D BV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Two Parts to Determine the Effect of NWT-03 on Blood Pressure in Healthy Subjects. Part 1: A Dose Ranging, Cross-over Study to Determine the Effect of 1g, 2g & 5gs of NWT-03 Versus Placebo on Blood Pressure in Healthy Subjects.
- Lead sponsor
- Newtricious R&D BV
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- Not reported
- Enrollment
- 92 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure